SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-005575
Filing Date
2024-02-27
Accepted
2024-02-27 18:10:33
Documents
2
Period of Report
2024-02-23

Document Format Files

Seq Description Document Type Size
1 form4-02272024_110225.html 4  
1 form4-02272024_110225.xml 4 7466
2 ex24-02272024_110225.htm EX-24 3499
  Complete submission text file 0001415889-24-005575.txt   12443
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
Teehan Brendan (Reporting) CIK: 0001891900 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 24689031